Arteris (AIP) Expected to Post Earnings on Thursday

Arteris (NASDAQ:AIP) is expected to be issuing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.05) per share and revenue of $23.4790 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million for the quarter, compared to the consensus estimate of $21.03 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Arteris Stock Performance

Shares of NASDAQ AIP opened at $30.11 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of -38.11 and a beta of 1.96. The stock’s fifty day moving average price is $36.41 and its two-hundred day moving average price is $25.86. Arteris has a one year low of $8.42 and a one year high of $50.26.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Rosenblatt Securities upped their price target on shares of Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Jefferies Financial Group lifted their price objective on shares of Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research note on Wednesday, May 13th. Weiss Ratings downgraded shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Northland Securities set a $38.00 target price on shares of Arteris in a research report on Wednesday, May 13th. Finally, Oppenheimer assumed coverage on shares of Arteris in a report on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $38.20.

Insider Activity at Arteris

In related news, CFO Nicholas B. Hawkins sold 5,377 shares of the company’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $38.78, for a total transaction of $208,520.06. Following the completion of the sale, the chief financial officer owned 103,172 shares of the company’s stock, valued at $4,001,010.16. This represents a 4.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO K Charles Janac sold 10,679 shares of the stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $35.90, for a total transaction of $383,376.10. Following the sale, the chief executive officer owned 175,148 shares in the company, valued at $6,287,813.20. The trade was a 5.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,364,949 shares of company stock worth $48,244,576 in the last quarter. 23.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Arteris

Hedge funds and other institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC bought a new stake in shares of Arteris during the 1st quarter worth approximately $1,621,000. Strs Ohio bought a new position in Arteris in the first quarter valued at approximately $104,000. Geode Capital Management LLC raised its position in Arteris by 4.8% during the second quarter. Geode Capital Management LLC now owns 652,754 shares of the company’s stock valued at $6,222,000 after purchasing an additional 30,018 shares in the last quarter. Rhumbline Advisers raised its position in Arteris by 35.8% during the second quarter. Rhumbline Advisers now owns 54,416 shares of the company’s stock valued at $519,000 after purchasing an additional 14,350 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Arteris by 8.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company’s stock worth $3,053,000 after purchasing an additional 25,448 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.